McKinsey: AI could generate $60B-$110B in annual value for pharma
HealthcareAIGuy · x · 2026-09-21
McKinsey estimates AI could generate $60B-$110B in annual economic value for the pharma and medical products industry, mainly by accelerating drug discovery, speeding development and approval, and improving drug marketing. The author shares additional supporting material in a follow-up link.
Related event: McKinsey: AI Could Generate Up to $110B Annually for Pharma(2 posts)→
More from Venture
- Grass clarifies finances: all revenue flows to foundation, third-party audited — Ronangmi · 2026-09-22
- Solo Dev Launches FlexQueries, a Pay-as-You-Go SEO Tool That Tracks ChatGPT and Perplexity Visibility — nazranf_ · 2026-09-22
- AMD hits $1 trillion market cap under Lisa Su, once near bankruptcy — firstadopter · 2026-09-22
- VC term sheets came from whaling expeditions — and Columbus got a 10% carry seed round — DenehyXXL · 2026-09-22
- Meta jumps 12% as Haus launches Architect, a causal MMM action engine for marketers — jacob_posel · 2026-09-22
- Robinhood has 200 tokenized stocks live and AI agents are already trading them — PeterDiamandis · 2026-09-22